Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.

Schuler CR, Virji MA, Deubner DC, Stanton ML, Stefaniak AB, Day GA, Park JY, Kent MS, Sparks R, Kreiss K.

Scand J Work Environ Health. 2012 May;38(3):270-81. doi: 10.5271/sjweh.3192. Epub 2011 Aug 29.

2.

Sensitization and chronic beryllium disease at a primary manufacturing facility, part 1: historical exposure reconstruction.

Virji MA, Park JY, Stefaniak AB, Stanton ML, Day GA, Kent MS, Kreiss K, Schuler CR.

Scand J Work Environ Health. 2012 May;38(3):247-58. doi: 10.5271/sjweh.3188. Epub 2011 Aug 17.

3.

Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.

Madl AK, Unice K, Brown JL, Kolanz ME, Kent MS.

J Occup Environ Hyg. 2007 Jun;4(6):448-66.

PMID:
17474035
4.

Sensitization and chronic beryllium disease at a primary manufacturing facility, part 2: validation of historical exposures.

Park JY, Virji MA, Stefaniak AB, Stanton ML, Day GA, Kent MS, Schuler CR, Kreiss K.

Scand J Work Environ Health. 2012 May;38(3):259-69. doi: 10.5271/sjweh.3187. Epub 2011 Aug 17.

6.

Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.

Schuler CR, Kent MS, Deubner DC, Berakis MT, McCawley M, Henneberger PK, Rossman MD, Kreiss K.

Am J Ind Med. 2005 Mar;47(3):195-205.

PMID:
15712254
7.

Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.

Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K.

Int Arch Occup Environ Health. 2001 Apr;74(3):167-76.

PMID:
11355290
8.

Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.

Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E.

Appl Occup Environ Hyg. 2001 May;16(5):579-92.

PMID:
11370937
9.

Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.

Stefaniak AB, Chipera SJ, Day GA, Sabey P, Dickerson RM, Sbarra DC, Duling MG, Lawrence RB, Stanton ML, Scripsick RC.

J Toxicol Environ Health A. 2008;71(22):1468-81. doi: 10.1080/15287390802349883.

PMID:
18836922
10.

Beryllium particulate exposure and disease relations in a beryllium machining plant.

Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS.

J Occup Environ Med. 2001 Mar;43(3):238-49.

PMID:
11285872
11.

A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.

Kolanz ME, Madl AK, Kelsh MA, Kent MS, Kalmes RM, Paustenbach DJ.

Appl Occup Environ Hyg. 2001 May;16(5):593-614. Review.

PMID:
11370938
12.

Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.

McCleskey TM, Buchner V, Field RW, Scott BL.

Rev Environ Health. 2009 Apr-Jun;24(2):75-115. Review.

PMID:
19658317
13.

Chronic beryllium disease and beryllium sensitization at Rocky Flats: a case-control study.

Viet SM, Torma-Krajewski J, Rogers J.

AIHAJ. 2000 Mar-Apr;61(2):244-54.

PMID:
10782196
14.

Assessment of the beryllium lymphocyte proliferation test using statistical process control.

Cher DJ, Deubner DC, Kelsh MA, Chapman PS, Ray RM.

Inhal Toxicol. 2006 Oct;18(11):901-10.

PMID:
16864408
15.

Long-term efficacy of a program to prevent beryllium disease.

Thomas CA, Deubner DC, Stanton ML, Kreiss K, Schuler CR.

Am J Ind Med. 2013 Jul;56(7):733-41. doi: 10.1002/ajim.22175. Epub 2013 Feb 28.

PMID:
23450749
16.

Chronic beryllium disease and sensitization at a beryllium processing facility.

Rosenman K, Hertzberg V, Rice C, Reilly MJ, Aronchick J, Parker JE, Regovich J, Rossman M.

Environ Health Perspect. 2005 Oct;113(10):1366-72. Erratum in: Environ Health Perspect. 2006 Apr;114(4):A214.

17.

Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.

Mikulski MA, Leonard SA, Sanderson WT, Hartley PG, Sprince NL, Fuortes LJ.

Am J Ind Med. 2011 Mar;54(3):194-204. doi: 10.1002/ajim.20913. Epub 2010 Oct 28.

PMID:
21298695
18.

Characteristics of beryllium exposure to small particles at a beryllium production facility.

Virji MA, Stefaniak AB, Day GA, Stanton ML, Kent MS, Kreiss K, Schuler CR.

Ann Occup Hyg. 2011 Jan;55(1):70-85. doi: 10.1093/annhyg/meq055. Epub 2010 Aug 30.

PMID:
20805261
19.

Exposure pathway assessment at a copper-beryllium alloy facility.

Day GA, Dufresne A, Stefaniak AB, Schuler CR, Stanton ML, Miller WE, Kent MS, Deubner DC, Kreiss K, Hoover MD.

Ann Occup Hyg. 2007 Jan;51(1):67-80. Epub 2006 Jul 14.

PMID:
16844720
20.

Genetic and exposure risks for chronic beryllium disease.

Maier LA.

Clin Chest Med. 2002 Dec;23(4):827-39. Review.

PMID:
12516537

Supplemental Content

Support Center